Literature DB >> 91761

In-vitro activity of cefotaxime against gentamicin and mezlocillin resistant strains.

I Braveny, H Dickert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 91761     DOI： 10.1016/s0140-6736(79)92604-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.

Authors:  C R Magnussen; M T Sammartino; K D Ernest
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

Review 2.  Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.